Estimated numbers of existing real-world clinical studies published on monoclonal antibodies for severe asthma
| Retrospective | Prospective | Registry | |
| Benralizumab | 9 | 3 | 0 |
| Dupilumab | 4 | 0 | 0 |
| Mepolizumab | 18 | 12 | 3 |
| Omalizumab | 30 | 13 | 5 |
| Reslizumab | 4 | 2 | 0 |
Data are presented as n. The studies are categorised as retrospective, prospective and registry studies. To obtain these data, we used the search string on PubMed: “omalizumab/dupilumab/reslizumab/mepolizumab/benralizumab asthma real world”. The search was performed in November 2021.